TACI/TNFRSF13B/CVID Antibody (MM0562-9D22) - Azide and BSA Free

Novus Biologicals | Catalog # NBP2-11937

Novus Biologicals
Loading...

Key Product Details

Species Reactivity

Human

Applications

Immunohistochemistry, Immunohistochemistry-Paraffin, Immunohistochemistry-Frozen, Western Blot, Block/Neutralize

Label

Unconjugated

Antibody Source

Monoclonal Mouse IgG1 Clone # MM0562-9D22

Format

Azide and BSA Free
Loading...

Product Specifications

Immunogen

Human recombinant TACI/TNFRSF13B/CVID (extracellular domain)

Clonality

Monoclonal

Host

Mouse

Isotype

IgG1

Applications for TACI/TNFRSF13B/CVID Antibody (MM0562-9D22) - Azide and BSA Free

Application
Recommended Usage

Immunohistochemistry

1:10-1:500

Immunohistochemistry-Frozen

1:20-1:200

Immunohistochemistry-Paraffin

1:10-1:500

Western Blot

1:500-1:1000

Formulation, Preparation, and Storage

Purification

Protein G purified

Reconstitution

Reconstitute with sterilized PBS to a final concentration of 0.5 mg/ml.

Formulation

Lyophilized from a 0.2 um filtered solution in PBS. 0.025 mg size is provided in liquid form, PBS

Format

Azide and BSA Free

Preservative

No Preservative

Concentration

LYOPH mg/ml

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.

Calculators

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Background: TACI/TNFRSF13B

TACI is a lymphocyte specific member of the tumor necrosis factor (TNF) receptor superfamily. It interacts with calcium-modulator and cyclophilin ligand (CAML). The protein binds to both APRIL and BAFF and induces activation of the transcription factors NFAT (nuclear-factor of activated T cells), AP1, and NF kappa B and plays a crucial role in humoral immunity by interacting with a TNF ligand. This gene is located within the Smith Magenis syndrome region on chromosome 17.

Long Name

Transmembrane Activator and CAML Interactor/Tumor Necrosis Factor Receptor Superfamily Member 13B

Alternate Names

CD267, CVID, TNFRSF13B

Gene Symbol

TNFRSF13B

UniProt

Additional TACI/TNFRSF13B Products

Product Documents for TACI/TNFRSF13B/CVID Antibody (MM0562-9D22) - Azide and BSA Free

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot or batch number in the search box below.

Product Specific Notices for TACI/TNFRSF13B/CVID Antibody (MM0562-9D22) - Azide and BSA Free

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Customer Reviews for TACI/TNFRSF13B/CVID Antibody (MM0562-9D22) - Azide and BSA Free

There are currently no reviews for this product. Be the first to review TACI/TNFRSF13B/CVID Antibody (MM0562-9D22) - Azide and BSA Free and earn rewards!

Have you used TACI/TNFRSF13B/CVID Antibody (MM0562-9D22) - Azide and BSA Free?

Submit a review and receive an Amazon gift card!

$25/€18/£15/$25CAN/¥2500 Yen for a review with an image

$10/€7/£6/$10CAN/¥1110 Yen for a review without an image

Submit a review
Amazon Gift Card

Protocols

Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.

FAQs for TACI/TNFRSF13B/CVID Antibody (MM0562-9D22) - Azide and BSA Free

Showing  1 - 1 of 1 FAQ Showing All
  • Q: I need to know what part of the TACI protein is targeted by your antibody NBP2-11937?

    A: Our CVID Antibody (MM0562-9D22) was raised against an immunogen found in the extracellular domain of the human Tumor necrosis factor receptor superfamily member 13B protein (amino acids 1-165). As this product has not been epitope mapped, we unfortunately do not know the exact epitope recognized by this antibody.

Showing  1 - 1 of 1 FAQ Showing All
View all FAQs for Antibodies